Press Releases

Predictmedix Deploys Safe Entry’s Fit for Duty Screening at LongArm Engineering

Nov 17, 2022 - Press Releases

LongArm Engineering to implement Safe Entry fitted with Fit for Duty Screening at Odessa Texas facility and new Corporate Office TORONTO, ON / ACCESSWIRE / November 17, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced the revenue-generating […]

Predictmedix Provides Business and Technology Development Updates and Closes Final Tranche of Private Placement

Nov 7, 2022 - Press Releases

TORONTO, ON / Preedictmedix / November 7, 2022 / Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE:PMED)(OTCQB:PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), announces that it has closed the final tranche of its non-brokered private placement. Pursuant to the final tranche, the Company has issued 1,600,000 units (the […]

Predictmedix Closes First Tranche of Private Placement

Aug 22, 2022 - Press Releases

Toronto, Ontario, August 22, 2022 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), announces that it has closed the first tranche of a non-brokered private placement (the “First Tranche”). Pursuant to the First Tranche, the Company has […]

Predictmedix and Partners Launch Safe Entry Station as a Comprehensive Fit for Duty Screening Solution at Electra Mining Africa and National Safety Council’s (NSC) Congress & Expo

Aug 8, 2022 - Press Releases

Toronto, ON, August 8, 2022  – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that its Safe Entry Station will be used as a comprehensive Fit for Duty screening solution for workplaces and industries around the world, detecting […]

Predictmedix Announces Accuracy Rates for Monitoring of Symptoms and Physiological Parameters

Jul 25, 2022 - Press Releases

Toronto, ON, July 25, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced its accuracy rates for identifying Respiration Rate, Heart Rate, and Core Body Temperature as part of its Fit for Work screening solutions for industries […]

Predictmedix Receives $1.85 Million Letter of Intent for 80 Safe Entry Stations from KaTron Defence Space and Simulation Technologies

Jun 29, 2022 - Press Releases

Toronto, ON, June 29, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that it has received a non-binding Letter of Intent (LOI) from KaTron Defence Space and Simulation Technologies, a leading Turkish provider of simulation products […]

Predictmedix Secures Deployment of Safe Entry Stations at De Beers Forevermark Forum 2022

Jun 15, 2022 - Press Releases

High Visibility, Revenue Generating Deployment Provides Predictmedix with Strong Industry Validation   Toronto, ON – June 15, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that it has secured a revenue-generating deployment at the DeBeers Forevermark Forum […]

Predictmedix Reports Fiscal 2022 Financial Results

Jun 1, 2022 - Press Releases

TORONTO, ON / ACCESSWIRE / June 1, 2022 /Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today reported its financial and operational results for the fourth quarter and fiscal year ended January 31, 2022. Recent Fiscal 2022 and Subsequent Operational Highlights […]

Predictmedix to Present at 12th Annual LD Micro Invitational

May 24, 2022 - Press Releases

Interim CEO Dr. Rahul Kushwah to Present at 11:00 a.m. Pacific on June 7, 2022 TORONTO, ON / ACCESSWIRE / May 24, 2022 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that management will present at the 12th Annual LD […]

Predictmedix Showcases Safe Entry Station Technology at Major Las Vegas Entertainment Event

Apr 5, 2022 - Press Releases

Placement at Major Las Vegas Venue Served as Live, High-Profile Demonstration of Safe Entry Station to Area Entertainment and Hospitality Sector Representatives Toronto, ON, April 5, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced the conclusion […]

Predictmedix Inc. Issues Shareholder Letter and Provides Corporate Update on Key Milestone Achievements

Feb 10, 2022 - Press Releases

Toronto, ON, February 10, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today released a letter to shareholders from Interim Chief Executive Officer, Dr. Rahul Kushwah. Dear Fellow Shareholders, 2021 was an exciting and transformational year for Predictmedix. […]

Predictmedix To Launch Infectious Diseases Clinical Trial in North American Hospital for FDA Medical Device Classification of Safe Entry Stations

Jan 26, 2022 - Press Releases

Independent Study for Infectious Diseases Symptom Detection in a Clinical Setting to Provide Additional Third-Party Validation; Prerequisite Ahead of Planned FDA Certification as Class II Medical Device Toronto, ON – January 26, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial […]